Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homescience news

      science news

      Is It Too Late to Invest in Novavax Stock?
      Investing News

      Is It Too Late to Invest in Novavax Stock?

      October 20, 2022
      JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations 
      Uncategorized

      JNJ Stock Rises as FDA Approves the Use of Teligen System in Spinal Operations 

      October 20, 2022
      NVS Stock Rises as Nilotinib, a Leukemia Medication Is Licensed by Novartis to the Un-Backed Medicines Patent Pool
      Investing News

      NVS Stock Rises as Nilotinib, a Leukemia Medication Is Licensed by Novartis to the Un-Backed Medicines Patent Pool

      October 20, 2022
      Novavax Stock: Explaining Wednesday’s Decline
      Investing News

      Novavax Stock: Explaining Wednesday’s Decline

      October 19, 2022
      Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?
      Investing News

      Is Johnson & Johnson (Jnj) Stock Alpha Enough to Make It a Good Low Beta Stock?

      October 19, 2022
      Johnson and Johnson Stock Went Up After the Company Said It Would Report Earnings for the Third Quarter
      Investing News

      Johnson and Johnson Stock Went Up After the Company Said It Would Report Earnings for the Third Quarter

      October 17, 2022
      Pfizer Stock Dips as It Denies CEO Won EU COVID-19 Vaccine Contract Through Texting
      Investing News

      Pfizer Stock Dips as It Denies CEO Won EU COVID-19 Vaccine Contract Through Texting

      October 10, 2022
      Guggenheim Upgraded the Merck Stock to Buy, Noting the Company’s Projected Profits Growth.
      Investing News

      Guggenheim Upgraded the Merck Stock to Buy, Noting the Company’s Projected Profits Growth.

      October 10, 2022
      JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.
      Investing News

      JNJ Stock Fell as Long-Term Ulcerative Colitis Therapeutic Effects Were Highlighted.

      October 10, 2022
      Merck Stock Price Has Risen as a Result of Merck’s $500 Million Expansion in Singapore.
      Investing News

      Merck Stock Price Has Risen as a Result of Merck’s $500 Million Expansion in Singapore.

      October 6, 2022
      « 1 … 5 6 7 8 9 … 16 »

       

      LATEST NEWS

      • Investing News JPMorgan Q4 2025 Earnings Overview
      • Investing News As Netflix Drops 33%, Is NFLX Stock a Buy Ahead of Q4?
      • Investing News Will AAPL Stock Rebound in 2026?
      • Investing News Retail’s 2025 Holiday Growth
      • Investing News Goldman Sachs Earnings Lead Q1 Reports

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026